Site intended for UK audience


Osteoviva® contains the active substance ibandronic acid.

Osteoviva® belongs to a group of medicines called bisphosphonates. Osteoviva® can counteract bone loss by stopping further bone loss and increasing bone mass in most women who take it. Osteoviva® can help reduce the risk of bone fractures.

Osteoviva® is used to treat osteoporosis in postmenopausal women at increased risk of fractures.

Active substance: Ibandronic Acid

Strength Pack size
150 mg 1

Physicians / Pharmacists Login

We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.

Login Physicians / Pharmacists Login